Everolimus EP Impurity B
Product Type
Impurity Standards
CAT. No.
MRL-E25003
CAS. No.
1062122-63-7
Mol. F.
C53H83NO14
Mol. Wt.
958.2
Synonyms
Everolimus 19-Ene Open-Ring Impurity ; seco Everolimus
Chemical Name
(2S)-1-[[(2R,3R,6S)-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl]-3-methyloxan-2-yl](oxo)a
Stock Status
Custom Synthesis
Everolimus EP Impurity B with CAS No: 1062122-63-7 is an impurity standard of Everolimus. Everolimus is an immunosuppressive medication used in transplant medicine and oncology. As an inhibitor of the mammalian target of rapamycin (mTOR), everolimus interferes with cell signaling pathways involved in the regulation of cell growth, proliferation, and angiogenesis. In transplant medicine, everolimus is often used in combination with other immunosuppressive drugs to prevent organ rejection in kidney and liver transplant recipients. In oncology, everolimus has been approved for the treatment of various cancers, including advanced kidney cancer, breast cancer, and certain types of neuroendocrine tumors. Buy high quality Everolimus EP Impurity B from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of Everolimus EP Impurity B
